Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Flipkart explores US listing to strengthen position in Indian e-commerce market, says GlobalData

India-based Flipkart has benefited from the e-commerce surge during the COVID-19 pandemic and is now exploring going public in the US through a merger with a special-purpose acquisition company (SPAC). Unlike a traditional IPO process this approach is less intrusive with fewer disclosure requirements and as the competition intensifies in the Indian e-commerce market, it […]
Read more

Capco deal yields Wipro steep spike in influencer discussions on Twitter, observes GlobalData

India-based IT giant Wipro Limited (Wipro) has recently agreed to acquire London-headquartered global management and technology consultancy Capco for US$1.45bn. Subsequently, there was a 150% spike in influencer conversations on Wipro during the first week of March compared to the previous week, reveals GlobalData, a leading data and analytics company. This is Wipro’s largest ever […]
Read more

Ford Motor sees 200% growth in influencer conversations after doubling investment in EVs, reveals GlobalData

Ford Motor Company (Ford) doubled its investment in electric vehicles (EVs) while declaring better than expected quarterly earnings report for Q4 2020. This led to a staggering 200% jump in influencer conversations on Twitter during January-February 2021 over the previous two months, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s […]
Read more

AbbVie pips Gilead to dominate Japan’s hepatitis C virus digital marketing space, says GlobalData

The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and AbbVie. However, AbbVie has taken an edge over Gilead in terms of HCV-related digital initiatives, finds GlobalData, a leading data and analytics company. According to GlobalData’s ‘Pharmaceutical Intelligence Center’, the number of diagnosed prevalent cases of HCV […]
Read more

Gojek rivalry with Grab extends to digital payments with investment in Indonesia’s e-wallet LinkAja, says GlobalData

Following the news that Indonesia-based ride-hailing giant Gojek has invested in state-backed e-wallet LinkAja in a fresh funding round;   Aurojyoti Bose, Lead Analyst at GlobalData, a leading data and analytics company, offers his view: “Rising Internet penetration, increasing digitalization and the proliferation of websites have been driving e-wallets’ growth in Indonesia. The popularity of […]
Read more

Australia implantable ports market to grow at 4% CAGR through 2025, forecasts GlobalData

The implantable ports market in Australia is expected to grow at a compound annual growth rate (CAGR) of about 4% between 2020 and 2025, driven by aging population and technological advancements, forecasts GlobalData, a leading data and analytics company. GlobalData’s report, ‘Implantable Ports (Drug Delivery Devices) – Global Market Analysis and Forecast Model (COVID-19 market […]
Read more

Increasing desire to enhance physical appearance propelling body contouring market in South Korea, says GlobalData

With a greater number of patients seeking alternatives to traditional diet and exercise to achieve their ideal body image, there is a rising demand for body contouring devices market in South Korea making it the third largest market in Asia-Pacific (APAC), says GlobalData a leading data and analytics company. GlobalData’s report, ‘Body Contouring Devices (General […]
Read more

Australia will lead Asia-Pacific mobile communication segment growth through 2025, reveals GlobalData

Australia will witness the fastest compound annual growth rate (CAGR) of 15.4% in terms of mobile service revenues in the Asia-Pacific (APAC) region between 2020 and 2025, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s Asia-Pacific Mobile Communication Forecast Model reveals that as 5G service adoption starts growing in Australia […]
Read more

Launch of generic brands for expensive oncology drugs improves treatment affordability and access in India, says GlobalData

The Central Drugs Standard Control Organization (CDSCO) has recently approved several generic versions of sunitinib to treat kidney cancer. Against this backdrop, the approval of generic brands of expensive oncology drugs will not only help in reducing the cost of these life-saving drugs but also improve access and adherence to treatment in the future, says […]
Read more
1 … 154 155 156 157 158 … 206